IP Library Patent Application 16558489
Patent Application
App. No. 16/558,489

METHODS FOR MEASURING CARCINOEMBRYONIC ANTIGEN

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/558,489
Abstract

Disclosed herein are methods of accurately measuring carcinoembryonic antigen in a biological sample and methods of identifying and treating a mucinous cyst in a subject.

Claims (15)

1 .- 63 . (canceled)

64 . A method of measuring carcinoembryonic antigen in a biological sample, the method comprising:

diluting the biological sample with a diluent to form a diluted biological sample;

measuring the amylase level of the diluted biological sample; and

measuring carcinoembryonic antigen level in the diluted biological sample.

65 . The method of claim 64 , wherein the diluent is saline, Diluent Universal, or a combination thereof.

66 . The method of claim 64 , wherein the biological sample is undiluted prior to the diluting step.

67 . The method of claim 64 , wherein diluting the biological sample with a diluent comprises diluting the biological sample with a diluent at a ratio of biological sample to diluent of about 1:10 to about 1:50

68 . The method of claim 64 , wherein diluting the biological sample with a diluent comprises diluting the biological sample with a diluent at a ratio of about 1:10.

69 . The method of claim 64 , wherein diluting the biological sample with a diluent comprises diluting the biological sample with a diluent at a ratio of about 1:40.

70 . The method of claim 64 , wherein the biological sample is not present in sufficient volume to accurately measure carcinoembryonic antigen level prior to the diluting step.

71 . The method of claim 64 , wherein the biological sample has a high viscosity prior to the diluting step.

72 . The method of claim 71 , wherein the high viscosity is due to the presence of mucin in the biological sample.

73 . The method of claim 64 , wherein the carcinoembryonic antigen levels in the biological sample exceed the measurement capabilities of an instrument being used to measure carcinoembryonic antigen level prior to the diluting step.

74 . The method of claim 64 , wherein the biological sample is selected from pancreatic fluid, pancreatic cyst fluid and combinations thereof.

Assignments (4)
SECURITY INTEREST Recorded Nov 2, 2021
From: INTERPACE BIOSCIENCES, INC.; INTERPACE DIAGNOSTICS CORPORATION; INTERPACE DIAGNOSTICS, LLC; INTERPACE PHARMA SOLUTIONS, INC.
To: BROADOAK FUND V, L.P.
Reel/Frame 057988/0110 →
SECURITY INTEREST Recorded Oct 20, 2021
From: INTERPACE DIAGNOSTICS CORPORATION
To: COMERICA BANK
Reel/Frame 057851/0289 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2019
From: FINKELSTEIN, SYDNEY DAVID; JACKSON, SARA ANN; BLEICHER, JAMIE MICHELLE; ELLSWORTH, ERIC MATTHEW GAYLE; SMITH, DENNIS MORGAN
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 050246/0654 →
MERGER AND CHANGE OF NAME Recorded Sep 3, 2019
From: REDPATH INTEGRATED PATHOLOGY, INC.; INTERPACE DIAGNOSTICS CORPORATION
To: INTERPACE DIAGNOSTICS CORPORATION
Reel/Frame 050254/0978 →